VANGUARD ASSET MANAGEMENT, Ltd
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1680208
London, EC4N 8AF, X0
Position in BIO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,562,580
New position
Shares Held
16,368
first reported quarter
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $1,285,036,731 across 42 Medical Devices names. BIO ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,480,271 | $357,319,423 | |
| 2 | MDT |
Medtronic plc
|
2,585,862 | $224,064,942 | |
| 3 | SYK |
Stryker Corp
|
597,266 | $196,255,634 | |
| 4 | BSX |
Boston Scientific Corp
|
2,567,095 | $161,085,211 | |
| 5 | EW |
Edwards Lifesciences Corp
|
995,846 | $79,747,347 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
790,492 | $56,267,220 | |
| 7 | DXCM |
Dexcom Inc
|
670,503 | $42,107,588 | |
| 8 | STE |
STERIS plc
|
170,568 | $37,717,701 |
All Filings in BIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,562,580 | 16,368 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||